I-MED Pharma is a privately held company, headquartered in Montreal, Quebec, servicing Canadian ophthalmologists, optometrists and the global eye care community. Established in 1989, I-MED Pharma Inc. creates and distributes innovative medical, surgical and veterinary eye care products and is divided into two functional business units: Pharma and Animal Health.
I-MED PHARMA continually researches, develops and sources the most effective and advanced solutions to eye disorders like cataracts, corneal degenerations, dry eye, glaucoma and Meibomian gland disease. Our goal is to provide our customers with state-of-the-art diagnostics and effective treatment solutions for a wide range of ocular surface diseases.
I-MED Pharma is proud to have been at the forefront of treating Dry Eye Syndrome as a serious disease and invests heavily into education and developing effective dry eye products. Most recently, I-MED Pharma launched the world’s first hand-held in-vivo tear osmolarity test, the I-PEN® osmolarity device and has signed exclusive partnership agreements with leading distributors in major international markets. I-MED Pharma’s ocular surface disease product range includes diagnostic tools, ocular hygiene, nutrition, dry eye drops and ocular occlusion devices.
Schrijf u in voor de Simovision Nieuwsbrief en blijf 1x per maand op de hoogte.
Blijf op de hoogte